In a recent ABC News feature, Dotmatics VP of Science and Technology, Phil Mounteney, discusses the transformative role of artificial intelligence in drug development. The article explores how Dotmatics is helping scientific organizations move faster and smarter—turning data into decisions with the power of AI.
From streamlining early-stage research to enhancing collaboration and speeding up preclinical timelines, the Luma platform is changing the way life sciences companies innovate. In the wake of the pandemic and with the rise of mRNA and other advanced modalities, the need for connected, AI-ready data has never been greater.
Read the full article to learn how Dotmatics is shaping the future of R&D.
Learn More About Dotmatics
Schedule a meeting with our team to learn more about Luma's AI capabilities.